Ab Science Sa Stock Fundamentals
AB Stock | EUR 0.82 0.04 5.13% |
AB Science SA fundamentals help investors to digest information that contributes to AB Science's financial success or failures. It also enables traders to predict the movement of AB Science Stock. The fundamental analysis module provides a way to measure AB Science's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AB Science stock.
AB Science |
AB Science SA Company Shares Owned By Insiders Analysis
AB Science's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current AB Science Shares Owned By Insiders | 41.25 % |
Most of AB Science's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AB Science SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition |
Based on the latest financial disclosure, 41.25% of AB Science SA are shares owned by insiders. This is 171.74% higher than that of the Healthcare sector and notably higher than that of the Drug Manufacturers - Major industry. The shares owned by insiders for all France stocks is notably lower than that of the firm.
AB Science SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AB Science's current stock value. Our valuation model uses many indicators to compare AB Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AB Science competition to find correlations between indicators driving AB Science's intrinsic value. More Info.AB Science SA is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AB Science by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AB Science's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AB Science Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AB Science's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AB Science could also be used in its relative valuation, which is a method of valuing AB Science by comparing valuation metrics of similar companies.AB Science is currently under evaluation in shares owned by insiders category among its peers.
AB Science Fundamentals
Return On Asset | -0.43 | |||
Operating Margin | (12.22) % | |||
Current Valuation | 427.66 M | |||
Shares Outstanding | 46.86 M | |||
Shares Owned By Insiders | 41.25 % | |||
Shares Owned By Institutions | 1.79 % | |||
Price To Earning | (10.99) X | |||
Price To Sales | 193.66 X | |||
Revenue | 1.61 M | |||
Gross Profit | 1.5 M | |||
EBITDA | (11.14 M) | |||
Net Income | (14.19 M) | |||
Cash Per Share | 0.28 X | |||
Total Debt | 14.44 M | |||
Debt To Equity | 102.90 % | |||
Current Ratio | 1.08 X | |||
Book Value Per Share | (0.63) X | |||
Cash Flow From Operations | (17.18 M) | |||
Earnings Per Share | (0.43) X | |||
Target Price | 19.05 | |||
Number Of Employees | 100 | |||
Beta | 0.8 | |||
Market Capitalization | 314.67 M | |||
Total Asset | 21.27 M | |||
Retained Earnings | (144 M) | |||
Working Capital | 13 M | |||
Current Asset | 32 M | |||
Current Liabilities | 19 M | |||
Z Score | 4.2 | |||
Net Asset | 21.27 M |
About AB Science Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AB Science SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AB Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AB Science SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 123 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AB Science Stock
AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.